Literature DB >> 24582739

Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening.

Anne Brücken1, Pinar Kurnaz2, Christian Bleilevens2, Matthias Derwall2, Joachim Weis3, Kay Nolte3, Rolf Rossaint2, Michael Fries2.   

Abstract

PURPOSE: Argon at a dosage of 70% is neuroprotective when given 1 h after cardiac arrest (CA) in rats. In a rodent model, we investigated if the neuroprotective effects of argon are dose dependent and mediated by adenosine triphosphate dependent potassium (K(ATP)) channels.
METHODS: Forty-seven male Sprague-Dawley rats were subjected to 7 min of CA and 3 min of cardiopulmonary resuscitation (CPR). In protocol I animals were randomized to receive either 70% or 40% argon ventilation 1 h after successful CPR or no argon-treatment. Animals of the second protocol also received 1 h of 70% argon ventilation or no argon treatment but were randomized to a group receiving the K(ATP) channel blocker 5-hydroxydecanoate (5-HD). For all animals a neurological deficit score (NDS) was calculated daily for seven days following the experiment before the animals were killed and the brains harvested for histopathological analyses.
RESULTS: All animals survived. Control animals exhibited severe neurologic dysfunction at all points in time as measured with the NDS. Argon treated animals showed significant improvements in the NDS through all postoperative days in a dose dependent fashion. This was paralleled by a significant reduction in the neuronal damage index in the neocortex and the hippocampal CA 3/4 region. Administration of 5-HD neither abolished the positive effects on functional recovery nor on histopathologic changes observed in the argon group.
CONCLUSION: Our study demonstrates a dose dependent neuroprotective effect of argon administration in this rodent model, which is not mediated via ATP dependent potassium channels.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Argon; Brain; Cardiopulmonary resuscitation; Hypoxia-ischaemia; Neuroprotective agents; Reperfusion injury

Mesh:

Substances:

Year:  2014        PMID: 24582739     DOI: 10.1016/j.resuscitation.2014.02.014

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  23 in total

Review 1.  [Neuroprotection by noble gases: New developments and insights].

Authors:  A V Fahlenkamp; R Rossaint; M Coburn
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

2.  Timely and Appropriate Administration of Inhaled Argon Provides Better Outcomes for tMCAO Mice: A Controlled, Randomized, and Double-Blind Animal Study.

Authors:  Juan He; Ke Xue; Jiayi Liu; Jin-Hua Gu; Bin Peng; Lihua Xu; Guohua Wang; Zhenglin Jiang; Xia Li; Yunfeng Zhang
Journal:  Neurocrit Care       Date:  2022-02-08       Impact factor: 3.532

3.  Delayed argon administration provides robust protection against cardiac arrest-induced neurological damage.

Authors:  Anne Brücken; Pinar Kurnaz; Christian Bleilevens; Matthias Derwall; Joachim Weis; Kay Nolte; Rolf Rossaint; Michael Fries
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

4.  Argon attenuates multiorgan failure following experimental aortic cross-clamping.

Authors:  Guillaume Savary; Fanny Lidouren; Jérôme Rambaud; Matthias Kohlhauer; Thierry Hauet; Patrick Bruneval; Bruno Costes; Alain Cariou; Bijan Ghaleh; Nicolas Mongardon; Renaud Tissier
Journal:  Br J Clin Pharmacol       Date:  2018-03-23       Impact factor: 4.335

5.  Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation.

Authors:  Matthias L Riess; Timothy R Matsuura; Jason A Bartos; Martin Bienengraeber; Mohammed Aldakkak; Scott H McKnite; Jennifer N Rees; Tom P Aufderheide; Mohammad Sarraf; Robert W Neumar; Demetris Yannopoulos
Journal:  Resuscitation       Date:  2014-10-02       Impact factor: 5.262

6.  Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries?

Authors:  Felix Ulbrich; Ulrich Goebel
Journal:  Neural Regen Res       Date:  2015-07       Impact factor: 5.135

7.  Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4.

Authors:  Felix Ulbrich; Kai Kaufmann; Martin Roesslein; Franziska Wellner; Volker Auwärter; Jürgen Kempf; Torsten Loop; Hartmut Buerkle; Ulrich Goebel
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

Review 8.  Argon: systematic review on neuro- and organoprotective properties of an "inert" gas.

Authors:  Anke Höllig; Anita Schug; Astrid V Fahlenkamp; Rolf Rossaint; Mark Coburn
Journal:  Int J Mol Sci       Date:  2014-10-10       Impact factor: 5.923

9.  Brief inhalation of nitric oxide increases resuscitation success and improves 7-day-survival after cardiac arrest in rats: a randomized controlled animal study.

Authors:  Anne Brücken; Matthias Derwall; Christian Bleilevens; Christian Stoppe; Andreas Götzenich; Nadine T Gaisa; Joachim Weis; Kay Wilhelm Nolte; Rolf Rossaint; Fumito Ichinose; Michael Fries
Journal:  Crit Care       Date:  2015-11-17       Impact factor: 9.097

10.  A randomized trial of the effects of the noble gases helium and argon on neuroprotection in a rodent cardiac arrest model.

Authors:  Patrick Zuercher; Dirk Springe; Denis Grandgirard; Stephen L Leib; Marius Grossholz; Stephan Jakob; Jukka Takala; Matthias Haenggi
Journal:  BMC Neurol       Date:  2016-04-04       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.